Literature DB >> 8244129

Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis.

G Basilisco1, R Barbera, M Molgora, M Vanoli, P Bianchi.   

Abstract

This study examined the hypothesis that impaired oesophageal peristalsis was associated with delayed oesophageal clearance of acid in patients with progressive systemic sclerosis (PSS), some of whom are thought to have impaired oesophageal sensitivity to acid. Sixteen patients with PSS had: (a) oesophageal manometry and endoscopy; (b) acid perfusion of the oesophagus with simultaneous measurement of intraoesophageal pH during perfusion and for the next 10 minutes; (c) 22 hour monitoring of intraoesophageal pH; and (d) an evaluation of reflux symptoms during and after perfusion and during overnight pH monitoring. By oesophageal manometry, eight patients had normal peristalsis and eight patients had impaired peristalsis. Oesophageal endoscopy was unremarkable in patients with normal peristalsis, whereas all patients with impaired peristalsis had oesophagitis. The time needed to clear the oesophagus of perfused acid was shorter (p < 0.01) in patients with normal peristalsis and acid clearance time was significantly correlated (p < 0.01) with acid exposure time during overnight pH monitoring. During and after oesophageal perfusion, the nature, duration, and severity of symptoms did not differ between the groups, but overnight symptoms lasted longer (p < 0.05) in patients with impaired peristalsis. It is concluded that in PSS: (1) Impaired oesophageal motility delayed the clearance of acid and increased the exposure time to acid. (2) Acid clearance time is a useful parameter of impaired oesophageal motor function. The assessment of acid clearance time can be used as an alternative to overnight pH monitoring, to assess the impairment of oesophageal acid clearance. (3) Oesophageal sensitivity to acid was preserved in patients with impaired peristalsis and oesophagitis. (4) Reflux symptoms lasted longer in patients with prolonged oesophageal acid exposure but were still reported for a small fraction of the total acid exposure time. Thus, reflux symptoms reflect poorly prolonged exposure of the oesophagus to acid and are not a reliable guide to acid injury of the oesophagus in PSS.

Entities:  

Mesh:

Year:  1993        PMID: 8244129      PMCID: PMC1374407          DOI: 10.1136/gut.34.11.1487

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications.

Authors:  M B Orringer; L Dabich; C J Zarafonetis; H Sloan
Journal:  Ann Thorac Surg       Date:  1976-08       Impact factor: 4.330

2.  The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease.

Authors:  S Cohen; R Fisher; W Lipshutz; R Turner; A Myers; R Schumacher
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

3.  Esophageal deterioration in scleroderma.

Authors:  J M Garrett; R K Winkelmann; J F Schlegel; C F Code
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

4.  Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions.

Authors:  J E Richter; W C Wu; D N Johns; J N Blackwell; J L Nelson; J A Castell; D O Castell
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

5.  Determinants of esophageal acid clearance in normal subjects.

Authors:  J F Helm; W J Dodds; D R Riedel; B C Teeter; W J Hogan; R C Arndorfer
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

Review 6.  Pathogenesis of reflux esophagitis.

Authors:  W J Dodds; W J Hogan; J F Helm; J Dent
Journal:  Gastroenterology       Date:  1981-08       Impact factor: 22.682

7.  Peripheral neuropathy in course of progressive systemic sclerosis. Light and ultrastructural study.

Authors:  G Di Trapani; A Tulli; A La Cara; P Laurienzo; S Mazza; P David
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Autonomic neuropathy in systemic sclerosis: a case report and evaluation of six patients.

Authors:  C Sonnex; E Paice; A G White
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

10.  Esophagitis in scleroderma. Prevalence and risk factors.

Authors:  B J Zamost; J Hirschberg; A F Ippoliti; D E Furst; P J Clements; W M Weinstein
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

View more
  6 in total

1.  Intraesophageal pH monitoring during acid infusion in patients with systemic sclerosis.

Authors:  F Carola; P A Bianchi; G Basilisco
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Relation between esophageal acid exposure and esophageal peristalsis.

Authors:  Joseph C Yarze
Journal:  Dig Dis Sci       Date:  2008-01-19       Impact factor: 3.199

3.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

Review 4.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

5.  Differentiating Delayed Esophageal Clearance From Reflux in Scleroderma.

Authors:  Anusha Pasumarthi; Sheena Mago; Promila Banerjee; Micheal Tadros
Journal:  Cureus       Date:  2020-11-18

6.  Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls.

Authors:  Christian Lottrup; Anne L Krarup; Hans Gregersen; Per Ejstrud; Asbjørn M Drewes
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.